[go: up one dir, main page]

ES2052531T3 - Metodo para aumentar selectivamente la relacion de los componentes individuales del complejo antibiotico a 40926. - Google Patents

Metodo para aumentar selectivamente la relacion de los componentes individuales del complejo antibiotico a 40926.

Info

Publication number
ES2052531T3
ES2052531T3 ES87112862T ES87112862T ES2052531T3 ES 2052531 T3 ES2052531 T3 ES 2052531T3 ES 87112862 T ES87112862 T ES 87112862T ES 87112862 T ES87112862 T ES 87112862T ES 2052531 T3 ES2052531 T3 ES 2052531T3
Authority
ES
Spain
Prior art keywords
ratio
individual components
selectively increasing
antibiotic complex
antibiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87112862T
Other languages
English (en)
Inventor
Enrico Selva
Maurizio Denaro
Luciano Gastaldo
Giovanni Cassani
Francesco Parenti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruppo Lepetit SpA
Original Assignee
Gruppo Lepetit SpA
Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruppo Lepetit SpA, Lepetit SpA filed Critical Gruppo Lepetit SpA
Application granted granted Critical
Publication of ES2052531T3 publication Critical patent/ES2052531T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/03—Actinomadura

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dental Preparations (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Silicon Polymers (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN METODO PARA MEJORAR SELECTIVAMENTE LA PRODUCCION DE LOS FACTORES A Y B0 DEL ANTIBIOTICO A/40926, BIEN PARA AISLAR ESTOS COMPONENTES CON MEJORES RENDIMIENTOS O PARA ENRIQUECER EL COMPLEJO EN UNO O AMBOS DE LOS CITADOS COMPONENTES, QUE IMPLICA A/ADIR UN PRECURSOR APROPIADO DEL FACTOR DESEADO A UN CULTIVO PRODUCTOR DE A/40926 DURANTE LA FERMENTACION.
ES87112862T 1986-09-11 1987-09-03 Metodo para aumentar selectivamente la relacion de los componentes individuales del complejo antibiotico a 40926. Expired - Lifetime ES2052531T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868621912A GB8621912D0 (en) 1986-09-11 1986-09-11 Increasing ratio of components of anti-biotic complex

Publications (1)

Publication Number Publication Date
ES2052531T3 true ES2052531T3 (es) 1994-07-16

Family

ID=10604036

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87112862T Expired - Lifetime ES2052531T3 (es) 1986-09-11 1987-09-03 Metodo para aumentar selectivamente la relacion de los componentes individuales del complejo antibiotico a 40926.

Country Status (15)

Country Link
US (1) US5843679A (es)
EP (1) EP0259781B1 (es)
JP (1) JP2520139B2 (es)
KR (1) KR960013575B1 (es)
AT (1) ATE82328T1 (es)
CA (1) CA1297055C (es)
DE (1) DE3782590T2 (es)
DK (1) DK165375C (es)
ES (1) ES2052531T3 (es)
GB (1) GB8621912D0 (es)
GR (1) GR3006262T3 (es)
HU (1) HU197771B (es)
IE (1) IE60419B1 (es)
IL (1) IL83735A (es)
ZA (1) ZA876774B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5606036A (en) * 1991-03-27 1997-02-25 Gruppo Lepetit Spa Antibiotic A 40926 ester derivatives
US5750509A (en) * 1991-07-29 1998-05-12 Gruppo Lepetit S.P.A. Amide derivatives of antibiotic A 40926
JP4051421B2 (ja) * 1995-07-05 2008-02-27 サノフイ−アベンテイス・エツセ・ピー・アー 等電点電気泳動によるダルバヘプチド抗生物質の精製
EP1213298A1 (en) * 2000-12-04 2002-06-12 Biosearch Italia S.p.A. Antibiotics GE 23077, pharmaceutically acceptable salts and compositions, and use thereof
EP1413626A1 (en) * 2002-10-23 2004-04-28 Vicuron Pharmaceuticals, Inc. Genes and proteins for the biosynthesis of the glycopeptide antibiotic A40926
RU2333766C2 (ru) * 2002-11-18 2008-09-20 Вайкьюрон Фармасьютикалз Инк. Способы введения далбаванцина для лечения бактериальных инфекций
HUE041133T2 (hu) * 2002-11-18 2019-05-28 Vicuron Pharmaceuticals Llc Dalbavancin adagolási módszer bakteriális fertõzések kezelésére
US7119061B2 (en) * 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
US20060074014A1 (en) 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
CN101851277B (zh) * 2009-03-12 2012-10-03 成都雅途生物技术有限公司 一种道古霉素关键中间体a40926 bo组分的纯化制备方法
CN110183519B (zh) * 2019-05-06 2023-04-11 大邦(湖南)生物制药有限公司 一种达巴万星关键中间体a40926的分离纯化方法
CN112480214B (zh) * 2020-12-14 2023-03-28 成都雅途生物技术有限公司 一种达巴万星关键中间体a40926的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8420405D0 (en) * 1984-08-10 1984-09-12 Lepetit Spa Preparing antibiotic l 17046
GB8425685D0 (en) * 1984-10-11 1984-11-14 Lepetit Spa Antibiotic a 40926 complex
NL8403377A (nl) * 1984-11-06 1986-06-02 Schuitemaker Mach Bv Opraaploswagen.
GB8512795D0 (en) * 1985-05-21 1985-06-26 Lepetit Spa Increasing ratio of components of teicoplanin a2 complex
GB8531846D0 (en) * 1985-12-30 1986-02-05 Lepetit Spa Antibiotic a 40926 mannosyl aglycon
GB8608809D0 (en) * 1986-04-11 1986-05-14 Lepetit Spa Antibiotic
GB8608798D0 (en) * 1986-04-11 1986-05-14 Lepetit Spa Recovery of glycopeptide antibiotics from aqueous solutions
GR871488B (en) * 1986-10-10 1987-11-12 Lepetit Spa New antibiotics
ES2084595T3 (es) * 1988-12-27 1996-05-16 Lepetit Spa Procedimiento quimico mejorado para preparar el antibiotico l/17392 (desglucoteicoplanina) y sus sales.
US5194424A (en) * 1988-12-27 1993-03-16 Gruppo Lepetit Spa C63 -amide derivatives of 34-de(acetylglucosaminyl)-34-deoxy-teicoplanin and their use as medicaments against bacteria resistant to glycopeptide antibiotics
EP0479086B1 (en) * 1990-10-01 1995-09-06 GRUPPO LEPETIT S.p.A. Teicoplanin recovery process
US5606036A (en) * 1991-03-27 1997-02-25 Gruppo Lepetit Spa Antibiotic A 40926 ester derivatives

Also Published As

Publication number Publication date
US5843679A (en) 1998-12-01
DE3782590D1 (de) 1992-12-17
EP0259781B1 (en) 1992-11-11
CA1297055C (en) 1992-03-10
HU197771B (en) 1989-05-29
KR960013575B1 (ko) 1996-10-09
DK165375B (da) 1992-11-16
HUT46744A (en) 1988-11-28
ATE82328T1 (de) 1992-11-15
ZA876774B (en) 1988-06-29
IE60419B1 (en) 1994-07-13
KR880004095A (ko) 1988-06-01
DE3782590T2 (de) 1993-03-25
DK461887A (da) 1988-03-12
EP0259781A2 (en) 1988-03-16
GR3006262T3 (es) 1993-06-21
GB8621912D0 (en) 1986-10-15
IL83735A (en) 1992-02-16
DK165375C (da) 1993-04-05
IE872420L (en) 1988-03-11
JP2520139B2 (ja) 1996-07-31
EP0259781A3 (en) 1990-05-02
JPS6377892A (ja) 1988-04-08
DK461887D0 (da) 1987-09-04
IL83735A0 (en) 1988-02-29

Similar Documents

Publication Publication Date Title
DE69133332D1 (de) Menschliche hematopoietische Stammzellen
ES2052531T3 (es) Metodo para aumentar selectivamente la relacion de los componentes individuales del complejo antibiotico a 40926.
FI872580A7 (fi) Menetelmä meripihkahapon valmistamiseksi anaerobisen käymisen avulla.
IL84285A0 (en) Polynucleotide molecule,chimeric antibody with specificity to human tumor antigen,process for the preparation thereof and methods utilizing the same
FI874082A0 (fi) Menetelmä glykopeptidiantibioottien valmistamiseksi ja niitä tuottavia mikro-organismiviljelmiä
JPS57105191A (en) Production of human urogastrone
DE69022595D1 (de) Herstellung von kohlefaser-halbfabrikaten.
DE68909077D1 (de) Gamma-Linolensäure oder Dihomo-gamma-Linolensäure enthaltende Zubereitung zur Verbesserung der Haut.
IL83736A0 (en) Method for selectively increasing the ratio of single major components of antibiotic a/16686 complex
ATE41034T1 (de) Herstellung von protein a.
DE69315752D1 (de) Tieftemperatur-Verfahren zur Herstellung von mit Alpha-Anomeren angereicherten 2-Deoxy-2,2-Difluor-D-Ribofuranosyl-Sulfonaten
HUT46662A (en) Process for producing alkyl-melatonins
CA1262912C (en) TETRAHYDROFURANYLIC SUBSTITUTION DERIVATIVES OF PROSTAGLANDIN ANALOGS
DE3784795D1 (de) Verfahren zur herstellung von 5,6-substituierten-2,4-chinazolindiaminen und zwischenprodukten.
DE3782169D1 (de) Verfahren zur herstellung von antibiotica 10381b.
DE3574932D1 (de) Verwendung von 1,4 bisubstituierten anthrachinonen zur herstellung von immunsuppressiva.
BG44029A3 (en) Method for preparing of n- dimethyl morphinanic derivatives
DE3884741D1 (de) Mikrobiologisches Verfahren zur Herstellung von UK-61.689 und Mikroorganismen zur Verwendung darin.
ATE121746T1 (de) Verfahren zur herstellung bissilylierter 3- iodmethylcephalosporinderivaten.
BG47345A3 (en) Method for preparing of dialkyloxalacetates
ATA102287A (de) Verfahren zur herstellung von neuen 8- bzw. 1,8- substituierten ergolenderivaten
BG28850A4 (bg) Метод за получаване на антибиотик а-28086
DE3875885D1 (de) Methode zur herstellung von polycyclischen 1,3-thiazolidinen.
HUT64372A (en) Method for producing optically pure dyestuff concentrates from natural raw materials
ES2003533A6 (es) Procedimiento para la obtencion de enantiomeros de monoesteres de acido dicarboxilicos opticamente activos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 259781

Country of ref document: ES